GEODE CAPITAL MANAGEMENT, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 86 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$25,414,137
+8.0%
1,240,160
+4.7%
0.00%0.0%
Q2 2023$23,528,133
+18.8%
1,184,103
+2.5%
0.00%0.0%
Q1 2023$19,797,815
+91760.7%
1,155,739
+4.9%
0.00%0.0%
Q4 2022$21,552
-99.8%
1,101,320
+28.2%
0.00%
+50.0%
Q3 2022$13,713,000
+23.3%
859,219
+6.3%
0.00%0.0%
Q2 2022$11,124,000
-6.3%
808,463
+8.0%
0.00%
+100.0%
Q1 2022$11,874,000
-27.9%
748,737
-0.8%
0.00%
-50.0%
Q4 2021$16,473,000
-26.7%
754,627
+0.4%
0.00%
-33.3%
Q3 2021$22,473,000
-31.6%
751,861
+1.3%
0.00%
-40.0%
Q2 2021$32,858,000
+7.9%
741,887
+8.1%
0.01%0.0%
Q1 2021$30,455,000
-7.5%
686,389
+14.3%
0.01%
-16.7%
Q4 2020$32,939,000
+171.3%
600,640
+13.1%
0.01%
+200.0%
Q3 2020$12,139,000
+5.6%
531,032
-3.3%
0.00%0.0%
Q2 2020$11,491,000
+58.6%
549,048
+5.7%
0.00%0.0%
Q1 2020$7,246,000
-66.0%
519,456
-44.5%
0.00%0.0%
Q4 2019$21,316,000
+293.8%
936,610
+101.6%
0.00%
+100.0%
Q3 2019$5,413,000
-18.7%
464,651
+4.7%
0.00%
-50.0%
Q2 2019$6,657,000
+14.6%
443,814
+34.0%
0.00%0.0%
Q1 2019$5,808,000
-34.0%
331,154
-44.3%
0.00%
+100.0%
Q4 2018$8,804,000
+61.0%
594,064
+167.5%
0.00%
-50.0%
Q3 2018$5,468,000
+101.9%
222,109
+61.0%
0.00%
+100.0%
Q2 2018$2,708,000
+79.6%
137,974
+71.4%
0.00%
Q1 2018$1,508,00080,4780.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders